Homoeopathy in the management of irritable bowel syndrome.

Efficacy of Individualized Homoeopathic medicines or Bowel nosodes compared to placebo in irritable bowel syndrome: A three-armed, randomized, parallel group, placebo-controlled, double-blind, interventional trial. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/12/060858

Enrollment

Registered

2023-12-27

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K58- Irritable bowel syndrome

Interventions

Intervention1: Individualized homoeopathic medicines + dietary modifications: Known homoeopathic pharmacopoeial preparations in different potencies along with dietary modifications for 6 months. Inter

Eligibility

Inclusion criteria

Inclusion criteria: i)Patients fulfilling the Rome IV criteria. ii)Adults both male and female aged 18 to 60 years. iii)The willingness to document bowel symptoms and medication use regularly and to complete the assessments.

Exclusion criteria

Exclusion criteria: i)Pregnant or breast feeding female. ii)Patient who had prior abdominal surgery which may cause bowel symptoms similar to IBS. iii)Those who had other gastro-intestinal diseases including Colitis, Crohn’s disease, Coeliac disease and Chronic pancreatitis. iv)Those who were currently participating in another trial or had been in a trial within the previous three months. v)Patient with any uncontrolled co-morbidities (Hypertension, Diabetes Mellitus, Liver disease, kidney disease, heart disease, hypo or hyperthyroidism etc.) vi)Patients who are alcoholics. vii)Patient taken antispasmodics, opiates/anti-diarrhoeal drugs, NSAIDs, long-term antibiotics, other anti- inflammatory drugs in the last 15 days. viii)Poor treatment compliance (e.g. unstable working and living situation, difficult follow-up).

Design outcomes

Primary

Measure	Time frame
To evaluate the changes in quality of life using IBS-QoL over 6 months.Timepoint: At baseline and then every month over 6 months	—

Secondary

Measure	Time frame
To compare the changes in stool culture before and after homoeopathic treatment.Timepoint: At baseline and at end of 6 months;To compare the changes in the IBS-SSS scores from baseline over 6 months.Timepoint: Fortnightly for 6 months;To evaluate the mean stool consistency using Bristol Stool Form Score over 6 months.Timepoint: Fortnightly for 6 months	—

Countries

India

Contacts

Public ContactDr Shweta Gautam

Dr D P Rastogi Central Research Institute for Homoeopathy

dr.shwetagtm@gmail.com9999566890

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026